Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vivace Therapeutics

Vivace Therapeutics
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
$25M LATEST DEAL AMOUNT
5 INVESTORS
Description

Provider of a novel targeted cancer therapy. The company is engaged in targeting novel pathway for the treatment of cancer.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 2929 Campus Drive
  • Suite 405
  • San Mateo, CA 94403
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Vivace Therapeutics’s full profile, request a free trial.

Vivace Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 28-Jun-2017 $25M 0000 0000 Completed Startup
1. Early Stage VC (Series A) 20-Jan-2015 0000 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Vivace Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Vivace Therapeutics Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immatics Venture Capital-Backed Tübingen, Germany 00 00000 00000000000 00000
000000000 Private Equity-Backed Camarillo, CA 00 000 00 000000 000
000000000000000 Venture Capital-Backed Saint Louis, MO 0 00.000 000000000 00.000
00000 Venture Capital-Backed Boston, MA 0 0000 000
00000000 000000000 Angel-Backed Pasadena, CA 0 00.000 0000000000 00.000
To view this company’s complete list of competitors, request access »

Vivace Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cenova Capital Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
Canaan Partners Venture Capital Minority 000 0000 000000 0
Mission Bay Capital Venture Capital Minority 000 0000 000000 0
WuXi Healthcare Ventures Corporate Venture Capital Minority 000 0000 000000 0

Vivace Therapeutics Executive Team (6)

Name Title Board
Seat
Contact
Info
Bin Liu Ph.D Scientific Co-Founder
Andrei Konradi Ph.D Vice President & Head of Chemistry
Shuang Qiao Ph.D President, Chief Executive Officer and Director
Leonard Post Ph.D Chief Scientific Officer & Board Member
Kun-Liang Guan Ph.D Scientific Co-Founder

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Vivace Therapeutics Board Members (6)

Name Representing Role Since Contact
Info
Edward Hu Vivace Therapeutics Board Member 000 0000
Jun Wu Vivace Therapeutics Board Member 000 0000
Leonard Post Ph.D Self Chief Scientific Officer & Board Member 000 0000
Shuang Qiao Ph.D Self President, Chief Executive Officer and Director 000 0000
Tim Shannon Vivace Therapeutics Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »